供应商 · 生产商
enginzyme
EnginZyme 的抱负是通过让每个行业用上绿色化学,在应对气候变化中发挥关键作用:打造世界迄今最通用、最高效的化学生产技术平台——这是一个宏大的主张,但公司能够撑得起。以无细胞生物制造平台对化学工业进行“生物升级”,就能以真正可持续的方式生产现代社会所依赖的产品;该技术平台利用自然的催化剂——酶——把生物学的力量与化学工业的效率结合成两全其美的方案。EnginZyme 被世界经济论坛评为技术先锋,获 Sofinnova Partners、Industrifonden、SEB Greentech VC、Bunge Ventures、Almi Invest GreenTech Fund 和 Navigare Ventures 支持。
简介
- 行业
- 化妆品, 生物工艺设备, 工业化学
- 主题
- 酶与生物催化, 合成生物学平台与生物制造
- 角色
- 生产商 — “…ce traditional fossil-based manufacturing methods [1][4][3]. The company is privately held and recently closed…”
- 为何属于生物经济
- EnginZyme 是生物技术公司,开发面向可持续化学制造和生物催化的无细胞酶基平台。
- 发现途径
- Novonesis; AB Enzymes; [Rubric] Finland · lipase-oils; [Rubric] Norway · lipase-oils
供应的生物解决方案 0
尚未被列为已评级方案的供应商。
产品与服务
该公司未公开其产品或服务——我们可通过引荐了解。
状态
近期新闻 5
精选自公开商业披露与权威行业资讯。引用或用于商业决策前,请以官方原文公告为准。
- 2026-10-02 Enginzyme Raises SEK 75 Million To Advance Commercial Biomanufacturing Strategy pulse2.comEnginzyme has raised SEK 75 million to shift from R&D toward commercial biomanufacturing, expanding adoption of its enzyme-based, cell-free manufacturing technology for personal care, food, and pharma, with new investors joining the board to support scalable, sustainable …
- 2026-09-23 Enginzyme Raises SEK 75 Million to Advance Its Commercial Biomanufacturing Strategy - BioSpace biospace.comEnginzyme has closed a SEK 75 million equity round, signaling a strategic shift from R&D toward commercial biomanufacturing in personal care, food, and pharmaceutical applications. The funding brings in new shareholders and board members to support its enzyme immobilization …
- 2026-09-23 Enginzyme AB Closes New Equity Round Raising SEK 75 Million — TradingView News tradingview.comEnginzyme AB has closed a new equity round, raising SEK 75 million, signaling investor confidence and potential growth funding for the company.
- 2026-09-23 Enginzyme Raises SEK 75 Million to Advance Its Commercial Biomanufacturing Strategy | Business Wire via.tt.seEnginzyme has raised SEK 75 million in a new equity round, signaling a strategic shift from R&D toward a commercially driven biomanufacturing agenda. The funding, including new shareholders and board members, supports its goal of delivering cost-efficient, sustainable …
- 2026-09-23 EnginZyme raises US$9.07M to shift from R&D to commercial biomanufacturing | Dealroom News dealroom.coEnginZyme has closed a US$9.07M Series C to pivot from R&D toward commercial biomanufacturing, strengthening its leadership with new investors including Lotus One Investment and Valquest Partners Europe. The funding supports scaling enzyme-based, non-chemical production across …
关系网络:股东、合作伙伴、同类
股权与投资方 5
| 投资方 | Almi Invest GreenTech |
| 投资方 | Bunge Ventures |
| 投资方 | Sofinnova Partners |
| 投资方 | Industrifonden |
| 投资方 | SEB GreenTech VC |
同类企业
C3 Biotech · GFBiochemicals · DAB.bio · Green Biologics Ltd. · NorFalk · Biochemtex · Cascat GmbH · Arsenale Bioyards
公司信息
注册编号
- Registration number: 556965-8494
融资
- 最近一轮: Non equity assistance · 2024-09-05
- 累计融资: US$ 34.8 M
核心运营指标与商业动态汇编自企业年报、行业披露及公开工商信息,法定登记编码以主管部门官方登记为准。
身份与联系方式
联系方式、人员和法律信息仅向会员开放。
会员登录